For Patients

Diabetes

Patient checking blood glucose leve

Subscribe to FDA Diabetes Monitor

FDA’s Diabetes Monitor delivers e-mail updates on safety and regulatory issues related to diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.

An estimated 29.1 million (21.0 million diagnosed and 8.1 million undiagnosed) people in the U.S. — approximately 9.3% of the population — have diabetes. An estimated 86 million people in the U.S. (1 out of 3 adults) have prediabetes and 9 out of 10 people in the U.S. do not know they have prediabetes.With the incidence of diabetes skyrocketing, it is important that the FDA do what we can to inform patients and the health professionals. FDA is committed to getting accurate, science-based information in the hands of people with diabetes and the people who provide medical care - so they can recommend and use foods, medicines, and devices to maintain and improve patient health.

What’s new in Diabetes? 

 
2016 Updates
2015 Updates
Meetings
  • FDA-Patient Dialogue on Unmet Needs in Diabetes Meeting was held on Monday, November 3, 2014. FDA hosted a discussion with Type 1 and Type 2 diabetes communities to provide FDA with real-world perspectives as the agency deliberates complex policies that affect the safety and effectiveness of marketed products on which people with diabetes depend.

  • Diabetes Live Chat. On March 31, 2014, discussion was held on the FDA’s new proposed guidelines and what standards blood glucose meters should have to meet before the FDA clears them for sale. View our recent LiveChat with Bennett Dunlap creator of StripSafety.com and FDA's Courtney Lias Ph.D, Director of Chemistry and Toxicology Devices. 

Podcast/Webinar's      

 

Page Last Updated: 07/11/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.